среда, 27 апреля 2011 г.

FDA Approves Benicar for the Hypertension Treatment in Children and Adolescents 6-16 old

FDA Approves Benicar for the Hypertension Treatment in Children and Adolescents 6-16 old.


US Food and Drug Administration (FDA) has approved the curing of euphoric blood influence Benicar (olmesartan medoxomil) for use in children and adolescents 6 to 16 years of age liprocil and cialis side affects. Benicar was from the outset approved in 2002 for the therapy of hypertension in adults.



Approximately 5 percent, or 3,6 million, American children be reduced from maximum blood pressure, with the preponderance inobservant they have the condition. Studies have also found that the commonplace blood insistence of American children is on the rise, in equivalent with the increase of children's weight Duphaston efectos. In fact, an inquiry of nearly 40 years of civil surveys of high blood compel trends in children and adolescents showed that the prevalence of glad blood pressure among this group has been growing since the departed 1980's.



A "As hypertension is on the take off also in a younger population, Daiichi Sankyo believes it is worthy to help doctors meet the dare of treating these pediatric patients by providing a remedying option to help people effectively preside over their hypertension," said Reinilde Heyrman, MD, Vice President Clinical Development - Operations, Daiichi Sankyo Pharma Development.



Pediatric hypertension is closely linked to boyhood obesity, as pot-bellied children are at approximately a three-fold higher endanger for hypertension than non-obese children. Additionally hypertension during teens has been shown to be an confident hazard factor for hypertension in adulthood, and to be associated with antique markers of cardiovascular disease, making it consequential to treat this working order in children and adolescents.



The approval of this expanded implication was based on a phase III study examining the antihypertensive chattels of Benicar in pediatric patients. The learning found Benicar to be safe and effective in children ages 6-16 with hypertension, resulting in blood intimidation reductions that were statistically various in comparison to placebo. Benicar was generally well tolerated in pediatric patients, and the adverse issue outline was similar to that for adults.



Benicar is an angiotensin II receptor blocker (ARB), which blocks the performance of a quintessence in the body called angiotensin II that increases blood pressure. It is indicated for the healing of hypertension in adults as well as pediatric patients 6-16 years of age, merely or with other antihypertensive agents.



About Benicar. Angiotensin II is a hormone that interacts with a receptor on arterial blood vessels, which results in constriction and increasing blood pressure. In addition, angiotensin II stimulates the launch of another hormone that causes enhanced sodium and chloride (salt) retention, with a resultant dilate in vascular dishwater retention and blood size that also contributes to an uplifting in blood pressure. Benicar is a colleague of the ARB distinction of antihypertensive medications that inform soften blood make by blocking the angiotensin II receptor on the blood vessels, which may while away to antagonizing the unloose of the hormone which causes kippered retention and increased blood volume.



Benicar is indicated for the care of hypertension in adults and pediatric patients 6 to 16 years of age, solo or with other antihypertensive agents abortion medicine islamabad. Benicar may be Euphemistic pre-owned as introductory therapy.

Комментариев нет:

Отправить комментарий